Redefining the Value Proposition of Precision Oncology: Can We Integrate Genomic Testing Without Overselling It?

JAMA Oncol. 2018 Oct 1;4(10):1423-1424. doi: 10.1001/jamaoncol.2018.3729.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Genetic Testing
  • Genomics
  • Humans
  • Lung Neoplasms*
  • Neoplasms / genetics*
  • Precision Medicine